You are here

  • Home
  • Archive
  • Volume 67, Issue 7
  • Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

Article metrics

Article menu
Download PDFPDF
Commentary
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2025

AbstractFullPdf
Jan 20184225125
Feb 20183662517
Mar 2018175169
Apr 201899157
May 201820283
Jun 20184054225
Jul 20181703023
Aug 2018101138
Sep 201810079
Oct 201878138
Nov 2018118610
Dec 2018941116
Jan 201910266
Feb 20196056
Mar 201980210
Apr 20195235
May 20197554
Jun 20192643
Jul 20195443
Aug 20197349
Sep 20193653
Oct 20194559
Nov 201953316
Dec 20192401
Jan 20202501
Feb 20205703
Mar 20204535
Apr 20202413
May 20201301
Jun 20202200
Jul 20202713
Aug 20203203
Sep 20207517
Oct 20202604
Nov 20204115
Dec 20203901
Jan 20212602
Feb 20214234
Mar 20211602
Apr 20212702
May 20211103
Jun 2021211
Jul 2021301
Aug 2021763
Sep 2021322
Oct 20213636
Nov 20213310
Dec 20212441
Jan 20224054
Feb 20221821
Mar 20223100
Apr 20223510
May 20225211
Jun 20225021
Jul 20222521
Aug 20226321
Sep 20225310
Oct 20225110
Nov 20223731
Dec 20222422
Jan 20231510
Feb 20236511
Mar 20233021
Apr 2023410
May 20232220
Jun 2023400
Jul 20232521
Aug 20231810
Sep 20231410
Oct 20232600
Nov 20231521
Dec 20233800
Jan 2024613
Feb 20241400
Mar 20241500
Apr 20243311
May 20242500
Jun 20242401
Jul 20242500
Aug 20241933
Sep 20241611
Oct 20241200
Nov 20242410
Dec 20241510
Jan 20253300
Feb 2025610
Mar 2025600
Apr 2025500
Total4699354323